Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.23% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Energy | 12.48% |
| 4 | Technology | 11.83% |
| 5 | Communication Services | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WFM
101
DELISTED
Whole Foods Market Inc
WFM
| $235M | 0.22% |
6,094,666
-11,697,522
| -66% | -$510M |
|
102
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
| $235M | 0.22% |
+1,200,000
| New | +$228M |
|
103
Pacira BioSciences
PCRX
$1.03B
| $232M | 0.21% |
2,529,910
-102,906
| -4% | -$7.84M |
|
|
KATE
104
DELISTED
Kate Spade & Company
KATE
| $232M | 0.21% |
6,092,055
+2,597,066
| +74% | +$93M |
|
|
INVX
105
Innovex International
INVX
$2.11B
| $220M | 0.2% |
2,017,006
+9,081
| +0.5% | +$976K |
|
106
IDEX
IEX
$17B
| $220M | 0.2% |
2,724,824
-365,560
| -12% | -$27.7M |
|
107
Herc Holdings
HRI
$5.03B
| $216M | 0.2% |
2,567,253
+919,888
| +56% | +$77.5M |
|
|
WDR
108
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $216M | 0.2% |
3,447,667
+379,309
| +12% | +$24.5M |
|
|
GG
109
DELISTED
Goldcorp Inc
GG
| $215M | 0.2% |
7,691,365
+203,842
| +3% | +$5.06M |
|
110
Dollar Tree
DLTR
$24.1B
| $209M | 0.19% |
3,842,234
-16,676
| -0.4% | -$877K |
|
|
FTR
111
DELISTED
Frontier Communications Corp.
FTR
| $209M | 0.19% |
2,387,105
-113,585
| -5% | -$9.83M |
|
|
IHS
112
DELISTED
IHS INC CL-A COM STK
IHS
| $208M | 0.19% |
1,535,046
+59,116
| +4% | +$7.37M |
|
113
Teva Pharmaceuticals
TEVA
$42.5B
| $206M | 0.19% |
3,922,185
+193,895
| +5% | +$9.91M |
|
114
Occidental Petroleum
OXY
$59.1B
| $205M | 0.19% |
2,081,421
+68,331
| +3% | +$6.42M |
|
115
Oneok
OKE
$59.7B
| $202M | 0.19% |
2,974,362
-106,367
| -3% | -$6.73M |
|
116
PNC Financial Services
PNC
$96.6B
| $202M | 0.19% |
2,272,212
-5,650
| -0.2% | -$483K |
|
117
Roper Technologies
ROP
$42.2B
| $202M | 0.19% |
1,381,508
+50,287
| +4% | +$7.02M |
|
118
Ametek
AME
$54.2B
| $201M | 0.18% |
3,841,084
-331,219
| -8% | -$17.4M |
|
119
Comcast
CMCSA
$96B
| $201M | 0.18% |
7,477,020
+15,644
| +0.2% | +$402K |
|
120
Bunge Global
BG
$22.2B
| $200M | 0.18% |
2,648,147
-36,096
| -1% | -$2.79M |
|
121
Liberty Global Class C
LBTYK
$3.56B
| $200M | 0.18% |
5,839,928
-32,922
| -0.6% | -$1.09M |
|
122
Cheniere Energy
LNG
$58.3B
| $196M | 0.18% |
2,740,284
-3,787,733
| -58% | -$230M |
|
123
Amphenol
APH
$194B
| $191M | 0.18% |
15,896,560
+85,288
| +0.5% | +$1.02M |
|
124
PUT
Invesco QQQ Trust
QQQ
$489B
| $188M | 0.17% |
+2,000,000
| New | +$179M |
|
125
Microsoft
MSFT
$3.81T
| $187M | 0.17% |
4,486,291
+34,209
| +0.8% | +$1.38M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Energy.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.